- About Us
- Contact Us
Today, the House Energy & Commerce Committee held a hearing to examine the Health Resources and Services Administration (HRSA) oversight of the 340B Drug Pricing Program. The 340B Program was created in 1992, to enable “covered entities”, such as Disproportionate Share Hospitals (DSHs), Children’s Hospitals, Federally Qualified Health Centers (FQHCs), HIV/AIDS Programs and […]
Day 3 of the HCPCS Public Meeting highlighted payment issues surrounding wound closure devices. The device manufacturers represented shared many of the same concerns as applicants on prior days of not having accurate codes to reflect the different clinical applications of their devices.
Wound closure technology has advanced so rapidly, that many of these devices […]